1. Breast cancer in young women and prognosis: How important are proliferation markers?. (October 2017) Authors: Fredholm, Hanna; Magnusson, Kristina; Lindström, Linda S.; Tobin, Nicholas P.; Lindman, Henrik; Bergh, Jonas; Holmberg, Lars; Pontén, Fredrik; Frisell, Jan; Fredriksson, Irma Journal: European journal of cancer Issue: Volume 84(2017) Page Start: 278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Interval breast cancer is associated with interferon immune response. (February 2022) Authors: Ugalde-Morales, Emilio; Grassmann, Felix; Humphreys, Keith; Li, Jingmei; Eriksson, Mikael; Tobin, Nicholas P.; Lindström, Linda S.; Vallon-Christersson, Johan; Borg, Åke; Hall, Per; Czene, Kamila Journal: European journal of cancer Issue: Volume 162(2022) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial. Issue 35 (10th December 2022) Authors: Johansson, Annelie; Dar, Huma; van 't Veer, Laura J.; Tobin, Nicholas P.; Perez-Tenorio, Gizeh; Nordenskjöld, Anna; Johansson, Ulla; Hartman, Johan; Skoog, Lambert; Yau, Christina; Benz, Christopher C.; Esserman, Laura J.; Stål, Olle; Nordenskjöld, Bo; Fornander, Tommy; Lindström, Linda S. Journal: Journal of clinical oncology Issue: Volume 40:Issue 35(2022) Page Start: 4071 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗